These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 18936777)

  • 1. Cancer exploiting complement: a clue or an exception?
    Loveland BE; Cebon J
    Nat Immunol; 2008 Nov; 9(11):1205-6. PubMed ID: 18936777
    [No Abstract]   [Full Text] [Related]  

  • 2. Modulation of the antitumor immune response by complement.
    Markiewski MM; DeAngelis RA; Benencia F; Ricklin-Lichtsteiner SK; Koutoulaki A; Gerard C; Coukos G; Lambris JD
    Nat Immunol; 2008 Nov; 9(11):1225-35. PubMed ID: 18820683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dark side of C5a in sepsis.
    Ward PA
    Nat Rev Immunol; 2004 Feb; 4(2):133-42. PubMed ID: 15040586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement drives glucosylceramide accumulation and tissue inflammation in Gaucher disease.
    Pandey MK; Burrow TA; Rani R; Martin LJ; Witte D; Setchell KD; Mckay MA; Magnusen AF; Zhang W; Liou B; Köhl J; Grabowski GA
    Nature; 2017 Mar; 543(7643):108-112. PubMed ID: 28225753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C5a and Fcgamma receptors: a mutual admiration society.
    Atkinson JP
    J Clin Invest; 2006 Feb; 116(2):304-6. PubMed ID: 16453017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement inhibition keeps mothers calm and avoids fetal rejection.
    Girardi G
    Immunol Invest; 2008; 37(5):645-59. PubMed ID: 18716942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer and complement.
    Ostrand-Rosenberg S
    Nat Biotechnol; 2008 Dec; 26(12):1348-9. PubMed ID: 19060872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutting edge: critical role for C5aRs in the development of septic lymphopenia in mice.
    Grailer JJ; Fattahi F; Dick RS; Zetoune FS; Ward PA
    J Immunol; 2015 Feb; 194(3):868-72. PubMed ID: 25539817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional identification of the stable transfection C5aR cell line Molt-4.
    Zhang C; Xu R; Wang J; Han G; Chen G; Wang R; Wei H; Shen B; Ma Y; Li Y
    Cell Mol Immunol; 2007 Dec; 4(6):461-5. PubMed ID: 18163958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The complement factor C5a receptor is upregulated in NFL-/- mouse motor neurons.
    Humayun S; Gohar M; Volkening K; Moisse K; Leystra-Lantz C; Mepham J; McLean J; Strong MJ
    J Neuroimmunol; 2009 May; 210(1-2):52-62. PubMed ID: 19286267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Never make assumptions: the complicated role of complement in urinary tract infections.
    Thurman JM; Nemenoff RA
    Kidney Int; 2016 Sep; 90(3):469-71. PubMed ID: 27521106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unwelcome complement.
    Markiewski MM; Lambris JD
    Cancer Res; 2009 Aug; 69(16):6367-70. PubMed ID: 19654288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement upregulation in photodynamic therapy-treated tumors: Role of Toll-like receptor pathway and NFkappaB.
    Korbelik M
    Cancer Lett; 2009 Aug; 281(2):232-8. PubMed ID: 19328626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C5a receptor expression in T lymphocytes.
    Zwirner J
    J Leukoc Biol; 2007 May; 81(5):1159. PubMed ID: 17284680
    [No Abstract]   [Full Text] [Related]  

  • 15. Complement C5a in the sepsis syndrome--too much of a good thing?
    Gerard C
    N Engl J Med; 2003 Jan; 348(2):167-9. PubMed ID: 12519929
    [No Abstract]   [Full Text] [Related]  

  • 16. Improving radiotherapy in immunosuppressive microenvironments by targeting complement receptor C5aR1.
    Beach C; MacLean D; Majorova D; Melemenidis S; Nambiar DK; Kim RK; Valbuena GN; Guglietta S; Krieg C; Darvish-Damavandi M; Suwa T; Easton A; Hillson LV; McCulloch AK; McMahon RK; Pennel K; Edwards J; O'Cathail SM; Roxburgh CS; Domingo E; Moon EJ; Jiang D; Jiang Y; Zhang Q; Koong AC; Woodruff TM; Graves EE; Maughan T; Buczacki SJ; Stucki M; Le QT; Leedham SJ; Giaccia AJ; Olcina MM
    J Clin Invest; 2024 Aug; 134(16):. PubMed ID: 39145459
    [No Abstract]   [Full Text] [Related]  

  • 17. Peripheral tolerance in CD8+ T cells.
    Srinivasan M; Frauwirth KA
    Cytokine; 2009 May; 46(2):147-59. PubMed ID: 19268604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Complement in kidney diseases].
    Cosio FG; Hebert LA
    Rev Clin Esp; 1996 Mar; 196 Spec No():36-43. PubMed ID: 9206807
    [No Abstract]   [Full Text] [Related]  

  • 19. The C-type lectin-like receptor CLEC-1, expressed by myeloid cells and endothelial cells, is up-regulated by immunoregulatory mediators and moderates T cell activation.
    Thebault P; Lhermite N; Tilly G; Le Texier L; Quillard T; Heslan M; Anegon I; Soulillou JP; Brouard S; Charreau B; Cuturi MC; Chiffoleau E
    J Immunol; 2009 Sep; 183(5):3099-108. PubMed ID: 19667084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C5a, but not C3a, increases VEGF secretion in ARPE-19 human retinal pigment epithelial cells.
    Cortright DN; Meade R; Waters SM; Chenard BL; Krause JE
    Curr Eye Res; 2009 Jan; 34(1):57-61. PubMed ID: 19172471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.